NewGenIvf Group Limited (NIVF) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 1.27M | 1.52M | 0 | 0 |
| Revenue Growth % | -16.18% | - | - | - |
| Medical Costs & Claims | 734.48K | 1.32M | 0 | 0 |
| Medical Cost Ratio % | 57.67% | 87.05% | - | - |
| Gross Profit | 539.13K | 196.82K | 0 | 0 |
| Gross Margin % | 42.33% | 12.95% | - | - |
| Gross Profit Growth % | 173.92% | - | - | - |
| Operating Expenses | 1.63M | 1.27M | 377.72K | 115.64K |
| OpEx / Revenue % | 127.85% | 83.32% | - | - |
| Depreciation & Amortization | 179.9K | 166.95K | 0 | 0 |
| Combined Ratio % | 185.51% | 170.37% | - | - |
| Operating Income | -1.09M | -1.27M | -377.72K | -115.64K |
| Operating Margin % | -85.51% | -83.32% | - | - |
| Operating Income Growth % | 13.97% | -994.8% | - | - |
| EBITDA | -909.22K | -1.1M | 127.02K | 474.36K |
| EBITDA Margin % | -71.39% | -72.33% | - | - |
| Interest Expense | 421.11K | 25.26K | 0 | 0 |
| Non-Operating Income | -967.54K | -311K | -504.74K | -590K |
| Pretax Income | -543K | -955K | 127.02K | 474.36K |
| Pretax Margin % | -42.63% | -62.85% | - | - |
| Income Tax | -487K | 0 | 0 | 0 |
| Effective Tax Rate % | 89.69% | 0% | 0% | 0% |
| Net Income | -108K | -955K | 127.02K | 474.36K |
| Net Margin % | -8.48% | -62.85% | - | - |
| Net Income Growth % | 88.69% | -301.32% | - | - |
| EPS (Diluted) | -13.79 | 95.95 | 68.08 | 158.37 |
| EPS Growth % | -114.37% | -39.41% | - | - |
| EPS (Basic) | -13.79 | 95.95 | 68.08 | 158.37 |
| Diluted Shares Outstanding | 196.08K | 87.4K | 87.4K | 87.4K |